Ligand (LGND) Stock Performance and Market Overview
Ligand (LGND) advanced 3.07 % during a 24‑hour period ending at 04:31 AM Central Europe on Thursday, 22 March 2026. The stock is currently priced at approximately USD 314.78 on major exchanges.
- Shares outstanding: 19.9 million
- Market capitalization: USD 5.9 billion
- Volume in the last 24 hours: USD 51.1 million
Since the close of the previous month, Ligand’s share price has increased 5.63 %. The simple moving average over the past 200 days is USD 248.06.
The 52‑week high was USD 326.63, reached on 08 July 2026. The 52‑week low was USD 175.89, recorded on 13 January 2026.
24‑Hour Performance of Related Stocks
| Ticker | 24‑hour change | Current price | Market cap | PE ratio (if available) |
|---|---|---|---|---|
| MXL (Maxlinear) | –4.67 % | USD 75.79 | USD 7 billion | — |
| NCLH (Norwegian Cruise Line Holdin) | +2.69 % | USD 15.59 | USD 7 billion | 9.6 |
| TAP (Molson Coors Beverage) | +2.21 % | USD 39.47 | USD 7 billion | 4.14 |
| MHK (Mohawk Industries) | +2.74 % | USD 118.04 | USD 7 billion | 15.22 |
| AAOI (Applied Optoelectronics) | –1.87 % | USD 77.32 | USD 7.1 billion | — |
Company Profile
Ligand Pharmaceuticals Incorporated is a biotechnology firm headquartered in San Diego, United States. The company focuses on developing therapeutics that regulate hormone‑activated intracellular receptors involved in genetic control of diseases, including gynecological disorders, certain cancers, cardiovascular, inflammatory, and skin diseases. Ligand is listed on the Nasdaq stock exchange; its initial public offering was on 18 November 1992. Further information is available on the company’s website at www.ligand.com .
